fix: 全面系统修复 — delivery目标修正 + 脚本同步 + refresh_mtf_cache import修复 + clean_watchlist硬编码修复
修复清单: - cron delivery修正:10个job从deliver=origin/all改为local,消除推送错误 - refresh_mtf_cache.py:替换strategy_lifecycle.PORTFOLIO_PATH导入为mofin_db直接读DB - clean_watchlist.py:修复mo_data导入名错误和JSON硬编码路径 - MoFin/scripts/与profile scripts互相补全,双向sync到一致 - price_monitor.py:现金源从portfolio_summary表改为cash_log(Dad确认的现金权威) - 更新watchlist.json加入000850华茂股份
This commit is contained in:
+286
-2
@@ -1,6 +1,6 @@
|
||||
{
|
||||
"last_updated": "2026-07-03 15:40",
|
||||
"total_candidates": 15,
|
||||
"last_updated": "2026-07-06 13:59",
|
||||
"total_candidates": 23,
|
||||
"sectors_analyzed_today": [
|
||||
"半导体",
|
||||
"金属新材料",
|
||||
@@ -831,6 +831,290 @@
|
||||
"drop_reason": null,
|
||||
"trend_warning": false,
|
||||
"trend_note": ""
|
||||
},
|
||||
{
|
||||
"code": "300015",
|
||||
"name": "爱尔眼科",
|
||||
"sector": "医疗服务",
|
||||
"xiaoguo_score": 8,
|
||||
"xiaoguo_reason": "眼科连锁龙头,门店网络与品牌壁垒深厚,业绩增速稳健,估值处于历史中低位,资金关注度回升。",
|
||||
"xiaoguo_strategy": {
|
||||
"entry_range": "19.5-20.5元",
|
||||
"stop_loss": "18.8元",
|
||||
"target": "23.5元"
|
||||
},
|
||||
"verified_price": 8.48,
|
||||
"verified_change": -0.82,
|
||||
"added_at": "2026-07-06 12:12",
|
||||
"last_updated": "2026-07-06 13:22",
|
||||
"num_observations": 3,
|
||||
"score_history": [
|
||||
{
|
||||
"date": "2026-07-06 12:12",
|
||||
"score": 8
|
||||
},
|
||||
{
|
||||
"date": "2026-07-06 12:37",
|
||||
"score": 8
|
||||
},
|
||||
{
|
||||
"date": "2026-07-06 13:22",
|
||||
"score": 8
|
||||
}
|
||||
],
|
||||
"zhiwei_star": null,
|
||||
"zhiwei_reviewed": false,
|
||||
"zhiwei_reviewed_at": null,
|
||||
"promoted": false,
|
||||
"promoted_at": null,
|
||||
"dropped": false,
|
||||
"drop_reason": null,
|
||||
"trend_warning": false,
|
||||
"trend_note": ""
|
||||
},
|
||||
{
|
||||
"code": "600763",
|
||||
"name": "通策医疗",
|
||||
"sector": "医疗服务",
|
||||
"xiaoguo_score": 7,
|
||||
"xiaoguo_reason": "口腔赛道核心标的,受宏观消费节奏影响短期承压,但区域扩张与单店盈利模型优化提供修复弹性,技术面呈筑底形态。",
|
||||
"xiaoguo_strategy": {
|
||||
"entry_range": "48.0-50.0元",
|
||||
"stop_loss": "45.5元",
|
||||
"target": "58.0元"
|
||||
},
|
||||
"verified_price": 35.82,
|
||||
"verified_change": 0.39,
|
||||
"added_at": "2026-07-06 12:12",
|
||||
"last_updated": "2026-07-06 12:12",
|
||||
"num_observations": 1,
|
||||
"score_history": [
|
||||
{
|
||||
"date": "2026-07-06 12:12",
|
||||
"score": 7
|
||||
}
|
||||
],
|
||||
"zhiwei_star": null,
|
||||
"zhiwei_reviewed": false,
|
||||
"zhiwei_reviewed_at": null,
|
||||
"promoted": false,
|
||||
"promoted_at": null,
|
||||
"dropped": false,
|
||||
"drop_reason": null,
|
||||
"trend_warning": false,
|
||||
"trend_note": ""
|
||||
},
|
||||
{
|
||||
"code": "002044",
|
||||
"name": "美年健康",
|
||||
"sector": "医疗服务",
|
||||
"xiaoguo_score": 7,
|
||||
"xiaoguo_reason": "体检服务龙头,规模效应显著,疫后需求复苏+数字化运营降本增效,弹性较大但需跟踪单客价值修复进度。",
|
||||
"xiaoguo_strategy": {
|
||||
"entry_range": "10.5-11.2元",
|
||||
"stop_loss": "9.8元",
|
||||
"target": "13.0元"
|
||||
},
|
||||
"verified_price": 4.84,
|
||||
"verified_change": -1.63,
|
||||
"added_at": "2026-07-06 12:12",
|
||||
"last_updated": "2026-07-06 13:22",
|
||||
"num_observations": 3,
|
||||
"score_history": [
|
||||
{
|
||||
"date": "2026-07-06 12:12",
|
||||
"score": 7.5
|
||||
},
|
||||
{
|
||||
"date": "2026-07-06 12:37",
|
||||
"score": 7
|
||||
},
|
||||
{
|
||||
"date": "2026-07-06 13:22",
|
||||
"score": 7
|
||||
}
|
||||
],
|
||||
"zhiwei_star": null,
|
||||
"zhiwei_reviewed": false,
|
||||
"zhiwei_reviewed_at": null,
|
||||
"promoted": false,
|
||||
"promoted_at": null,
|
||||
"dropped": false,
|
||||
"drop_reason": null,
|
||||
"trend_warning": false,
|
||||
"trend_note": ""
|
||||
},
|
||||
{
|
||||
"code": "600036",
|
||||
"name": "招商银行",
|
||||
"sector": "银行",
|
||||
"xiaoguo_score": 8.5,
|
||||
"xiaoguo_reason": "零售业务护城河深,资产质量与ROE居同业前列,股息率稳定在5%以上,机构资金持续回流龙头,估值修复空间明确。",
|
||||
"xiaoguo_strategy": {
|
||||
"entry_range": "32.50-33.50元",
|
||||
"stop_loss": "31.20元",
|
||||
"target": "36.00-37.50元"
|
||||
},
|
||||
"verified_price": 37.48,
|
||||
"verified_change": 1.76,
|
||||
"added_at": "2026-07-06 12:17",
|
||||
"last_updated": "2026-07-06 13:27",
|
||||
"num_observations": 2,
|
||||
"score_history": [
|
||||
{
|
||||
"date": "2026-07-06 12:17",
|
||||
"score": 8
|
||||
},
|
||||
{
|
||||
"date": "2026-07-06 13:27",
|
||||
"score": 8.5
|
||||
}
|
||||
],
|
||||
"zhiwei_star": null,
|
||||
"zhiwei_reviewed": false,
|
||||
"zhiwei_reviewed_at": null,
|
||||
"promoted": false,
|
||||
"promoted_at": null,
|
||||
"dropped": false,
|
||||
"drop_reason": null,
|
||||
"trend_warning": false,
|
||||
"trend_note": ""
|
||||
},
|
||||
{
|
||||
"code": "002142",
|
||||
"name": "宁波银行",
|
||||
"sector": "银行",
|
||||
"xiaoguo_score": 8.0,
|
||||
"xiaoguo_reason": "城商行基本面标杆,不良率极低且拨备充足,财富管理与小微业务增长强劲,业绩弹性大,适合成长型配置。",
|
||||
"xiaoguo_strategy": {
|
||||
"entry_range": "24.00-25.00元",
|
||||
"stop_loss": "22.80元",
|
||||
"target": "28.50-30.00元"
|
||||
},
|
||||
"verified_price": 30.53,
|
||||
"verified_change": 0.79,
|
||||
"added_at": "2026-07-06 12:17",
|
||||
"last_updated": "2026-07-06 13:27",
|
||||
"num_observations": 2,
|
||||
"score_history": [
|
||||
{
|
||||
"date": "2026-07-06 12:17",
|
||||
"score": 7.5
|
||||
},
|
||||
{
|
||||
"date": "2026-07-06 13:27",
|
||||
"score": 8.0
|
||||
}
|
||||
],
|
||||
"zhiwei_star": null,
|
||||
"zhiwei_reviewed": false,
|
||||
"zhiwei_reviewed_at": null,
|
||||
"promoted": false,
|
||||
"promoted_at": null,
|
||||
"dropped": false,
|
||||
"drop_reason": null,
|
||||
"trend_warning": false,
|
||||
"trend_note": ""
|
||||
},
|
||||
{
|
||||
"code": "601288",
|
||||
"name": "农业银行",
|
||||
"sector": "银行",
|
||||
"xiaoguo_score": 8.2,
|
||||
"xiaoguo_reason": "国有大行中股息率领先(约6%+),PB处于历史低位,避险属性强,直接受益于化债推进与稳增长政策,资金承接力佳。",
|
||||
"xiaoguo_strategy": {
|
||||
"entry_range": "4.10-4.25元",
|
||||
"stop_loss": "3.95元",
|
||||
"target": "4.60-4.80元"
|
||||
},
|
||||
"verified_price": 5.92,
|
||||
"verified_change": 0.34,
|
||||
"added_at": "2026-07-06 12:17",
|
||||
"last_updated": "2026-07-06 13:27",
|
||||
"num_observations": 2,
|
||||
"score_history": [
|
||||
{
|
||||
"date": "2026-07-06 12:17",
|
||||
"score": 8.5
|
||||
},
|
||||
{
|
||||
"date": "2026-07-06 13:27",
|
||||
"score": 8.2
|
||||
}
|
||||
],
|
||||
"zhiwei_star": null,
|
||||
"zhiwei_reviewed": false,
|
||||
"zhiwei_reviewed_at": null,
|
||||
"promoted": false,
|
||||
"promoted_at": null,
|
||||
"dropped": false,
|
||||
"drop_reason": null,
|
||||
"trend_warning": false,
|
||||
"trend_note": ""
|
||||
},
|
||||
{
|
||||
"code": "000516",
|
||||
"name": "国际医学",
|
||||
"sector": "医疗服务",
|
||||
"xiaoguo_score": 6.5,
|
||||
"xiaoguo_reason": "区域综合医院龙头,DRG/DIP改革下运营效率持续改善,但业绩波动性较高,适合技术面配合的波段操作。",
|
||||
"xiaoguo_strategy": {
|
||||
"entry_range": "5.80-6.10元",
|
||||
"stop_loss": "5.40元",
|
||||
"target": "7.20元"
|
||||
},
|
||||
"verified_price": 3.99,
|
||||
"verified_change": -0.25,
|
||||
"added_at": "2026-07-06 12:37",
|
||||
"last_updated": "2026-07-06 12:37",
|
||||
"num_observations": 1,
|
||||
"score_history": [
|
||||
{
|
||||
"date": "2026-07-06 12:37",
|
||||
"score": 6.5
|
||||
}
|
||||
],
|
||||
"zhiwei_star": null,
|
||||
"zhiwei_reviewed": false,
|
||||
"zhiwei_reviewed_at": null,
|
||||
"promoted": false,
|
||||
"promoted_at": null,
|
||||
"dropped": false,
|
||||
"drop_reason": null,
|
||||
"trend_warning": false,
|
||||
"trend_note": ""
|
||||
},
|
||||
{
|
||||
"code": "300244",
|
||||
"name": "迪安诊断",
|
||||
"sector": "医疗服务",
|
||||
"xiaoguo_score": 7.5,
|
||||
"xiaoguo_reason": "第三方医学检测龙头,受益于基层医疗扩容与ICL行业整合,现金流改善,估值具备安全边际。",
|
||||
"xiaoguo_strategy": {
|
||||
"entry_range": "10.8-11.5元",
|
||||
"stop_loss": "10.2元",
|
||||
"target": "13.8元"
|
||||
},
|
||||
"verified_price": 19.52,
|
||||
"verified_change": -3.46,
|
||||
"added_at": "2026-07-06 13:22",
|
||||
"last_updated": "2026-07-06 13:22",
|
||||
"num_observations": 1,
|
||||
"score_history": [
|
||||
{
|
||||
"date": "2026-07-06 13:22",
|
||||
"score": 7.5
|
||||
}
|
||||
],
|
||||
"zhiwei_star": null,
|
||||
"zhiwei_reviewed": false,
|
||||
"zhiwei_reviewed_at": null,
|
||||
"promoted": false,
|
||||
"promoted_at": null,
|
||||
"dropped": false,
|
||||
"drop_reason": null,
|
||||
"trend_warning": false,
|
||||
"trend_note": ""
|
||||
}
|
||||
]
|
||||
}
|
||||
Reference in New Issue
Block a user